Incorporation of wild-type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: Insight into the processes governing glycoprotein incorporation into retroviral particles

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9294-9302

  Henriksson, Peter ^a   Pfeiffer, Tanya ^a   Zentgraf, Hanswalter ^a   Alke, Alexandra ^a   Bosch, Valerie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA UROGASTRONE; GLYCOPROTEIN; RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGOLD STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; STEREOSPECIFICITY; VIRUS CELL INTERACTION; VIRUS MORPHOLOGY; VIRUS PARTICLE;

EID: 0032876838     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9294-9302.1999     Document Type: Article

References (28)

1. Bastiani, L., S. Laal, M. Kim, and S. Zolla-Pazner. 1997. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 71:3444-3450.
2. Bosch, V., and R. T. Schwarz. 1984. Processing of gPr92env, the precursor to the glycoproteins of Rous sarcoma virus: use of inhibitors of oligosaccharide trimming and glycoprotein transport. Virology 132:95-109.
3. Conte, M., and S. Matthews. 1998. Retroviral matrix proteins: a structural perspective. Virology 246:191-198.
4. Cosson, P. 1996. Direct interaction between the envelope and matrix protein of HIV-1. EMBO J. 15:5783-5788.
5. Dettenhofer, M., and X. F. Yu. 1999. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1460-1470.
6. Dong, J., M. G. Roth, and E. Hunter. 1992. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 66:7374-7382.
7. Endres, M. J., S. Jaffer, B. Haggerty, J. D. Turner, B. J. Doranz, P. J. O'Brian, D. L. Kolson, and J. A. Hoxie. 1997. Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor pseudotypes. Science 278:1462-1464.
8. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
9. Henriksson, P., and V. Bosch. 1998. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology 251:16-21.
10. Indraccolo, S., S. Minuzzo, F. Feroli, F. Mammano, F. Calderazzo, L. Chieco-Bianchi, and A. Amadori. 1998. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther. 5:209-217.
11. Johnson, J. E., W. Rodgers, and J. K. Rose. 1998. A plasma membrane localisation signal in the HIV-1 envelope cytoplasmic domain prevents localisation at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virology 251:244-252.
12. Kräusslich, H.-G., C. Ochsenbauer, A.-M. Traencker, K. Mergener, M. Fäcke, H. R. Gelderblom, and V. Bosch. 1993. Analysis of protein expression and virus-like particle formation in mammalian cells lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology 192:605-617.
13. Mammano, F., E. Kondo, J. Sodroski, A. Bukovsky, and H. G. Göttlinger. 1995. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:3824-3830.
14. + cells. J. Virol. 71:3341-3345.
15. Mebatsion, T., S. Finke, F. Weiland, and K.-K. Conzelmann. 1997. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90:841-847.
16. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272:263-267.
17. Pfeiffer, T., H. Zentgraf, B. Freyaldenhoven, and V. Bosch. 1997. Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle budding. J. Gen. Virol. 78:1745-1753.
18. Rao, T., A. S. Belyaev, E. Fry, P. Roy, I. M. Jones, and D. I. Stuart. 1995. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378:743-747.
19. Resh, M. D., and R. L. Erikson. 1985. Highly specific antibody to Rous sarcoma virus src gene product recognises a novel population of pp60v-src and pp60c-src molecules. J. Cell. Biol. 100:409-417.
20. Rittner, C., H. Stöppier, M. Pawlita, and G. Sczakiel. 1991. Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression. Methods Mol. Cell. Biol. 2:176-181.
21. Rolls, M. M., P. Webster, N. H. Balba, and J. K. Rose. 1994. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 79:497-506.
22. Schnell, M. J., J. E. Johnson, L. Buonocore, and J. K. Rose. 1997. Construction of a novel virus that targets HIV-1 infected cells and controls HIV-1 infection. Cell 90:849-857.
23. Schnierle, B. S., J. Stitz, V. Bosch, F. Nocken, H. Merget-Millitzer, M. Engelstädter, R. Kurth, B. Groner, and K. Cichutek. 1997. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA 94:8640-8645.
24. Ullrich, A., L. Coussens, J. S. Hayflick, T. J. Dull, A. Gray, A. W. Tam, J. Lee, Y. Yarden, T. A. Libermann, J. Sclessinger, J. Downward, E. L. Mayes, N. Whittle, M. D. Waterfield, and P. H. Seeburg. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425.
25. Waterfield, M. D., E. L. Mayes, P. Stroobant, P. L. Bennet, S. Young, P. N. Goodfellow, G. S. Banting, and B. Ozanne. 1982. A monoclonal antibody to the human epidermal growth factor receptor. J. Cell. Biochem. 20:149-161.
26. Wilk, T., T. Pfeiffer, and V. Bosch. 1992. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189:167-177.
27. Wilk, T., T. Pfeiffer, A. Bukovsky, G. Moldenhauer, and V. Bosch. 1996. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology 218:269-274.
28. Young, J. A. T., P. Bates, K. Willert, and H. E. Varmus. 1990 Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250:1421-1423.